Daiichi Sankyo and Lilly Announce TRILOGY ACS…
02:22 EDT 26 Aug 2012 | PharmPro
Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient® (Prasugrel) in Acute Coronary Syndrome UA/NSTEMI Patients to be Managed Medically without an Artery-Opening Procedure
Original Article: Daiichi Sankyo and Lilly Announce TRILOGY ACS…
More From BioPortfolio on "Daiichi Sankyo and Lilly Announce TRILOGY ACS…"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
